Additional information
| Active substance | AmlodipineValsartan |
|---|---|
| Formula | C20H25ClN2O5 |
| Side effects | Headache, swelling (edema), fatigue, dizziness, palpitations, flushing |
| Effects | Lowering of blood pressure, improvement in blood flow |
| Dosage (sports) | Not applicable |
| Dosage (medical) | 5-10 mg once daily |
| Half-life | 30-50 hours |
| Main action | Dilation of blood vessels (vasodilation) |
| Substance class | Calcium channel blocker |
| Chemical name | 3-Ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| Storage conditions | Store at room temperature away from moisture and heat |
| Trade name | Norvasc, among others |
| Blood pressure | Reduces blood pressure |
| WAREHOUSE | International Warehouse 2 |
| Also known as | Amlodipine besylate (when paired with besylate salt) |
| Lab Test | Not specifically required for monitoring amlodipine |
| Hepatotoxicity | Low risk |
| Water Retention | Possible, particularly ankle and foot swelling |
| Use in sports | Not typically used in sports |
| Manufacturer | Novartis |
Reviews
There are no reviews yet.